Genprex Signs Exclusive License to Additional Diabetes Techn

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...

Related Keywords

Texas , United States , George Gittes , Mark Berger , Rodney Varner , Division Of Pediatric Surgery , University Of Pittsburgh , Genprex Inc , University Of Pittsburgh School Medicine , Company Website , Drug Administration , University Of Pittsburgh Pitt , Exchange Commission , Chief Executive Officer , Chief Medical , Pediatric Surgery , Pittsburgh School , Non Human Primate , About Genprex , Nanoparticle Delivery System , Fast Track Designation , Language Concerning Forward Looking Statements , Private Securities Litigation Reform Act , Annual Report , Genprex , Nc ,